Glomerulopatia da C3, Coco (Novartis): "Accesso a terapia prima non disponibile"
Posted inApps Editors Pick Gadget Games Must Read Reviews Software Technology Uncategorized

Glomerulopatia da C3, Coco (Novartis): "Accesso a terapia prima non disponibile"

No Comments

(Adnkronos) – ‘piano di ricerca clinica per intervenire su meccanismi che provocano danno renale’

Comments

No comments yet. Why don’t you start the discussion?

Leave a Reply

Your email address will not be published. Required fields are marked *